For those of you who understand the economics of medicine/insurance better than I do: what effect, if any, will the new climate bill (and the healthcare portion of it) have on ophthalmology? Specifically, I’m asking about the ability of medicare to negotiate drug prices. I am guessing there will be some sort of impact on intravitreal injections.